Detection of Aristaless-related homeobox protein in ovarian sex cord-stromal tumors

Knific T, Tamara Knific, Frković Grazio S, Snježana Frković Grazio, Rižner TL, Tea Lanišnik Rižner
Experimental and molecular pathology · 2017 · vol. 104(1) , pp. 38–44 · doi:10.1016/j.yexmp.2017.12.005 · PMID:29275192 · W2781364817
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

This paper reports on the detection of the Aristaless-related homeobox protein (ARX) in ovarian sex cord-stromal tumors.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo examine the potential of ARX as a novel biomarker of ovarian endometriosis and other ovarian pathologies.MethodsThe mRNA level of ARX in ovarian endometriosis and normal endometrium samples was determined by real-time PCR, while the protein level was determined by Western blotting and immunohistochemical staining. Immunohistochemical analysis was performed on nearly 200 tissue samples of different ovarian pathologies. GraphPad Prism was used for statistical analysis.ResultsThe expression of ARX was significantly increased in ovarian endometriosis samples as compared to normal endometrium. Also Western blotting data showed higher ARX levels in the ovarian endometriosis samples versus normal endometrium. Immunohistochemical analysis revealed that the protein is localized in the ovarian stroma and does not originate from endometriosis. Further immunohistochemical analysis performed on several different non-neoplastic and neoplastic ovarian tissue samples revealed that in the non-neoplastic ovary ARX protein is present only in the stromal cells and their derivates (luteinized stromal cells, theca and Leydig cells) and not in granulosa cells, oocites, surface epithelium or rete ovarii, while all stromal and sex cord tumors showed strong nuclear staining for ARX. All other primary or metastatic epithelial tumors of the ovary were ARX negative.ConclusionsARX is not associated with endometriosis and cannot be used as a biomarker for ovarian endometriosis. ARX is present in ovarian stroma and cells derived from ovarian stroma as well as in all types of sex cord-stromal tumors of the ovary and could thus be used as a marker for sex cord-stromal differentiation in ovarian tumors.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Homeodomain Proteins Sex Cord-Gonadal Stromal Tumors Transcription Factors Adult Biomarkers, Tumor Biomarkers, Tumor Biomarkers, Tumor Endometriosis Endometriosis Endometriosis Female Homeodomain Proteins Homeodomain Proteins Humans Immunohistochemistry Middle Aged Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (39)

Source provenance

europepmc
last seen: 2026-08-18T06:10:16.649438+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:20:01.354358+00:00
License: CC0 · commercial use OK